Patents by Inventor John Donnelly

John Donnelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10398660
    Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal center, particularly for the imaging of tumors.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: September 3, 2019
    Assignee: The University of Melbourne
    Inventors: Paul Stephen Donnelly, Stacey Erin Rudd, Spencer John Williams
  • Publication number: 20190256119
    Abstract: A secure package delivery system comprises a lockable container configured for securement to a movable door or exterior wall of a building structure. The container includes a walled body and openable lid. A vertically and horizontally adjustable dolly handle assembly is slideably coupled to a rear of the body and operable to form an adjustable gap for receiving a portion of the door to trap and secure the container in place. The handle assembly is lockable in place to the container and in vertical position by a crank mechanism operated via a lever. The container further includes a movable securement aperture in the handle assembly and wall pin which permits securing the container to a wall via operation of handle assembly and crank mechanism. A movable latch operated by the crank mechanism secures the wall pin in the securement aperture to prevent removal of the container.
    Type: Application
    Filed: February 22, 2019
    Publication date: August 22, 2019
    Inventors: John Brilhante, Michael Donnelly
  • Patent number: 9720135
    Abstract: A reflective material comprising a multilayered array of particles encapsulated by a matrix material, the reflective material defining a primary surface, the reflective material exhibiting: (i) visible retroreflection of incident radiation, wherein a wavelength of visible retroreflected radiation decreases from a first visible wavelength at a first angle to the primary surface to a second, shorter wavelength of visible retroreflected radiation as the viewing angle to the primary surface increases; and (ii) Bragg diffraction of the incident radiation, wherein the wavelength of radiation Bragg diffracted normal to the primary surface is longer than the wavelength of visible radiation, such that no visible radiation is retroreflected or Bragg diffracted in a direction normal to the primary surface.
    Type: Grant
    Filed: May 1, 2014
    Date of Patent: August 1, 2017
    Assignee: PPG industries Ohio, Inc.
    Inventors: Noel R. Vanier, Xiangling Xu, Eldon L. Decker, Justin Bohn, John Donnelly, Beverly Bendiksen, Adam Choros
  • Patent number: 9688880
    Abstract: A dispersion of monodisperse similarly charged particles, the monodisperse particles having a maximum particle size dispersity of 10% and each particle having a surface with a minimum surface charge density of 1 ?C/cm2 and comprising pendant steric stabilizing groups.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: June 27, 2017
    Assignee: PPG Industries Ohio, Inc.
    Inventors: Noel R. Vanier, Xiangling Xu, Kurt G. Olson, Justin Bohn, John Donnelly
  • Publication number: 20170003105
    Abstract: This invention is a group of panels of bullet proof fiberglass, covered by any decorative material. Placed on any interior wall, the wall art composite serves two functions: The bullet resistant panels of fiberglass span the full length and height of the area being protected against a gun attack. This wall art covers the entire length and height of the area, concealing the bullet resistant function of the work.
    Type: Application
    Filed: March 7, 2014
    Publication date: January 5, 2017
    Inventor: Robert John Donnelly
  • Publication number: 20160297993
    Abstract: A dispersion of monodisperse similarly charged particles, the monodisperse particles having a maximum particle size dispersity of 10% and each particle having a surface with a minimum surface charge density of 1 ?C/cm2 and comprising pendant steric stabilizing groups.
    Type: Application
    Filed: April 9, 2015
    Publication date: October 13, 2016
    Inventors: Noel R. Vanier, Xiangling Xu, Kurt G. Olson, Justin Bohn, John Donnelly
  • Publication number: 20150316686
    Abstract: A reflective material comprising a multilayered array of particles encapsulated by a matrix material, the reflective material defining a primary surface, the reflective material exhibiting: (i) visible retroreflection of incident radiation, wherein a wavelength of visible retroreflected radiation decreases from a first visible wavelength at a first angle to the primary surface to a second, shorter wavelength of visible retroreflected radiation as the viewing angle to the primary surface increases; and (ii) Bragg diffraction of the incident radiation, wherein the wavelength of radiation Bragg diffracted normal to the primary surface is longer than the wavelength of visible radiation, such that no visible radiation is retroreflected or Bragg diffracted in a direction normal to the primary surface.
    Type: Application
    Filed: May 1, 2014
    Publication date: November 5, 2015
    Applicant: PPG Industries Ohio, Inc.
    Inventors: Noel R. Vanier, Xiangling Xu, Eldon L. Decker, Justin Bohn, John Donnelly, Beverly Bendiksen, Adam Choros
  • Patent number: 9057716
    Abstract: The disclosure provides compositions, methods and kits for assessing immunogenicity, potency, or both, of meningococcal capsular saccharide vaccines. The assessment is based upon measurement of binding of a bactericidal antibody to a capsular saccharide component in the vaccine.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: June 16, 2015
    Assignee: Novartis AG
    Inventors: Cristiana Balocchi, Enrico Luzzi, Marilena Paludi, Marzia Monica Giuliani, John Donnelly, Elena Mori
  • Publication number: 20140275348
    Abstract: Disclosed is a method of recovering inorganic pigment such as TiO2 from a coating composition that includes liquid, an organic component, and an inorganic component. The coating composition is thermally treated to remove at least a portion of the organic component and yield an inorganic pigment composition having a higher concentration of the inorganic pigment (TiO2) than in the original coating composition.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: PPG Industries Ohio, Inc.
    Inventors: Jane Valenta, Linda Anderson, David Asay, John Donnelly, Michael A. Mayo, Gregory J. McCollum, Michael Zalich, Kristi Kauffman, Roxalana L. Martin, Michael J. Pawlik, Stuart D. Hellring, Ruby Chakraborty
  • Publication number: 20140256849
    Abstract: Disclosed is a silicate-enclosed pigment composition comprising hollow silicate shells each defining a core and pigment particles received in the cores. Silicate-enclosed pigments may be produced by dispersing pigment particles in an aqueous solution of an alkali silicate and spray drying the dispersion to yield a plurality of silicate shells each defining a hollow core, wherein the pigment particles are received within the hollow cores.
    Type: Application
    Filed: March 11, 2013
    Publication date: September 11, 2014
    Applicant: PPG Industries Ohio, Inc.
    Inventors: Noel R. Vanier, John Donnelly, Joseph T. Valko
  • Patent number: 8771747
    Abstract: Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(?-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surface of the microparticles efficiently adsorb biologically active macromolecules, such as DNA, polypeptides, antigens, and adjuvants. Also provided are compositions of an oil droplet emulsion having a metabolizable oil and an emulsifying agent. Immunogenic compositions having an immunostimulating amount of an antigenic substance, and an immunostimulating amount of an adjuvant composition are also provided.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: July 8, 2014
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Derek O'Hagan, Gary S. Ott, John Donnelly, Jina Kazzaz, Mildred Ugozzoli, Manmohan Singh, John Barackman
  • Patent number: 8734832
    Abstract: Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(?-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surface of the microparticles efficiently adsorb biologically active macromolecules, such as DNA, polypeptides, antigens, and adjuvants. Also provided are compositions of an oil droplet emulsion having a metabolizable oil and an emulsifying agent. Immunogenic compositions having an immunostimulating amount of an antigenic substance, and an immunostimulating amount of an adjuvant composition are also provided.
    Type: Grant
    Filed: September 15, 2012
    Date of Patent: May 27, 2014
    Assignee: Novartis AG
    Inventors: Derek O'Hagan, Gary S. Ott, John Donnelly, Jina Kazzaz, Mildred Ugozzoli, Manmohan Singh, John Barackman
  • Patent number: 8609109
    Abstract: Provided herein are HIV vaccines comprising HIV polypeptide-encoding DNA adsorbed to PLG and/or HIV proteins. Also provided are methods of using these vaccines to generate immune responses in a subject.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: December 17, 2013
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: John Donnelly, Susan W. Barnett, Derek O'Hagan
  • Patent number: 8518694
    Abstract: A nucleic acid vector comprising: (i) a promoter; (ii) a sequence encoding a HML-2 polypeptide operably linked to said promoter; and (iii) a selectable marker. Preferred vectors comprise: (I) a eukaryotic promoter; (ii) a sequence encoding a HML-2 polypeptide downstream of and operably linked to said promoter, (iii) a prokaryotic selectable marker; (iv) a prokaryotic origin of replication; and (v) a eukaryotic transcription terminator downstream of and operably linked to said sequence encoding a HML-2 polypeptide. Vectors of the invention are particularly useful for expression of HML-2 polypeptides either in vitro (e.g. for later purification). Or in vivo (e.g. for nucleic acid immunization). They are well suited to nucleic acid immunization against prostrate tumors. A preferred HML-2 is PCAV, which is located in chromosome 22 at 20.428 megabases (22q11.2).
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: August 27, 2013
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Stephen Hardy, John Donnelly, Jan zur Megede
  • Publication number: 20130196352
    Abstract: The disclosure provides compositions, methods and kits for assessing immunogenicity, potency, or both, of meningococcal capsular saccharide vaccines. The assessment is based upon measurement of binding of a bactericidal antibody to a capsular saccharide component in the vaccine.
    Type: Application
    Filed: September 2, 2011
    Publication date: August 1, 2013
    Applicant: NOVARTIS AG
    Inventors: Cristiana Balocchi, Enrico Luzzi, Marilena Paludi, Marzia Monica Giuliani, John Donnelly, Elena Mori
  • Publication number: 20130195898
    Abstract: Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(?-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surface of the microparticles efficiently adsorb biologically active macromolecules, such as DNA, polypeptides, antigens, and adjuvants. Also provided are compositions of an oil droplet emulsion having a metabolizable oil and an emulsifying agent. Immunogenic compositions having an immunostimulating amount of an antigenic substance, and an immunostimulating amount of an adjuvant composition are also provided.
    Type: Application
    Filed: September 15, 2012
    Publication date: August 1, 2013
    Applicant: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Derek O'Hagan, Gary S. Ott, John Donnelly, Jina Kazzaz, Mildred Ugozzoli, Manmohan Singh, John Barackman
  • Publication number: 20130195923
    Abstract: Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(?-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surface of the microparticles efficiently adsorb biologically active macromolecules, such as DNA, polypeptides, antigens, and adjuvants. Also provided are compositions of an oil droplet emulsion having a metabolizable oil and an emulsifying agent. Immunogenic compositions having an immunostimulating amount of an antigenic substance, and an immunostimulating amount of an adjuvant composition are also provided.
    Type: Application
    Filed: September 14, 2012
    Publication date: August 1, 2013
    Applicant: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
    Inventors: Derek O'Hagan, Gary S. Ott, John Donnelly, Jina Kazzaz, Mildred Ugozzoli, Manmohan Singh, John Barackman
  • Patent number: 8309139
    Abstract: Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(?-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surface of the microparticles efficiently adsorb biologically active macromolecules, such as DNA, polypeptides, antigens, and adjuvants. Also provided are compositions of an oil droplet emulsion having a metabolizable oil and an emulsifying agent. Immunogenic compositions having an immunostimulating amount of an antigenic substance, and an immunostimulating amount of an adjuvant composition are also provided.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: November 13, 2012
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Derek O'Hagan, Gary S. Ott, John Donnelly, Jina Kazzaz, Mildred Ugozzoli, Manmohan Singh, John Barackman
  • Publication number: 20120207783
    Abstract: Provided herein are HIV vaccines comprising HIV polypeptide-encoding DNA adsorbed to PLG and/or HIV proteins. Also provided are methods of using these vaccines to generate immune responses in a subject.
    Type: Application
    Filed: December 22, 2011
    Publication date: August 16, 2012
    Inventors: John DONNELLY, Susan W. BARNETT, Derek O'HAGAN
  • Patent number: 8206749
    Abstract: Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(?-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surface of the microparticles efficiently adsorb biologically active macromolecules, such as DNA, polypeptides, antigens, and adjuvants. Also provided are compositions of an oil droplet emulsion having a metabolizable oil and an emulsifying agent. Immunogenic compositions having an immunostimulating amount of an antigenic substance, and an immunostimulating amount of an adjuvant composition are also provided.
    Type: Grant
    Filed: February 9, 2000
    Date of Patent: June 26, 2012
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Derek O'Hagan, Gary S. Ott, John Donnelly, Jina Kazzaz, Mildred Ugozzoli, Manmohan Singh, John Barackman